Logo image of VANI

VIVANI MEDICAL INC (VANI) Stock Fundamental Analysis

NASDAQ:VANI - Nasdaq - US92854B1098 - Common Stock - Currency: USD

1.15  +0.01 (+0.88%)

Premarket: 1.13 -0.02 (-1.74%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to VANI. VANI was compared to 188 industry peers in the Health Care Equipment & Supplies industry. The financial health of VANI is average, but there are quite some concerns on its profitability. VANI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year VANI has reported negative net income.
In the past year VANI has reported a negative cash flow from operations.
VANI had negative earnings in each of the past 5 years.
In the past 5 years VANI always reported negative operating cash flow.
VANI Yearly Net Income VS EBIT VS OCF VS FCFVANI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

VANI's Return On Assets of -67.00% is on the low side compared to the rest of the industry. VANI is outperformed by 73.40% of its industry peers.
The Return On Equity of VANI (-204.34%) is worse than 75.53% of its industry peers.
Industry RankSector Rank
ROA -67%
ROE -204.34%
ROIC N/A
ROA(3y)-46.43%
ROA(5y)-97.1%
ROE(3y)-95.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VANI Yearly ROA, ROE, ROICVANI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

VANI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VANI Yearly Profit, Operating, Gross MarginsVANI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, VANI has more shares outstanding
VANI has more shares outstanding than it did 5 years ago.
VANI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VANI Yearly Shares OutstandingVANI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
VANI Yearly Total Debt VS Total AssetsVANI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

VANI has an Altman-Z score of -5.38. This is a bad value and indicates that VANI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -5.38, VANI is not doing good in the industry: 71.81% of the companies in the same industry are doing better.
VANI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.38
ROIC/WACCN/A
WACCN/A
VANI Yearly LT Debt VS Equity VS FCFVANI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

VANI has a Current Ratio of 2.40. This indicates that VANI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.40, VANI is in line with its industry, outperforming 44.68% of the companies in the same industry.
A Quick Ratio of 2.40 indicates that VANI has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.40, VANI is in line with its industry, outperforming 54.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.4
Quick Ratio 2.4
VANI Yearly Current Assets VS Current LiabilitesVANI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

VANI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.00%, which is quite good.
EPS 1Y (TTM)14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -19.85% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y8.43%
EPS Next 2Y-2.14%
EPS Next 3Y-4.34%
EPS Next 5Y-19.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VANI Yearly Revenue VS EstimatesVANI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2029 2030 2031 50M 100M 150M 200M
VANI Yearly EPS VS EstimatesVANI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

VANI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year VANI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VANI Price Earnings VS Forward Price EarningsVANI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VANI Per share dataVANI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4

4.3 Compensation for Growth

VANI's earnings are expected to decrease with -4.34% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.14%
EPS Next 3Y-4.34%

More info and screens

0

5. Dividend

5.1 Amount

VANI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VIVANI MEDICAL INC

NASDAQ:VANI (6/6/2025, 8:00:02 PM)

Premarket: 1.13 -0.02 (-1.74%)

1.15

+0.01 (+0.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)N/A N/A
Inst Owners8.31%
Inst Owner Change-4.12%
Ins Owners48.98%
Ins Owner Change1.15%
Market Cap68.13M
Analysts82.22
Price Target5.1 (343.48%)
Short Float %0.98%
Short Ratio3.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.37%
Min EPS beat(2)-2.71%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)5.94%
Min EPS beat(4)-2.71%
Max EPS beat(4)18.3%
EPS beat(8)6
Avg EPS beat(8)3.48%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-16.67%
EPS NQ rev (1m)-5.26%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)10.9%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.86
P/tB 5.86
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS0
BVpS0.2
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -67%
ROE -204.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-46.43%
ROA(5y)-97.1%
ROE(3y)-95.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 94.78%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.4
Quick Ratio 2.4
Altman-Z -5.38
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)158.98%
Cap/Depr(5y)139.49%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.33%
EPS Next Y8.43%
EPS Next 2Y-2.14%
EPS Next 3Y-4.34%
EPS Next 5Y-19.85%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5.57%
EBIT Next 3Y-15.98%
EBIT Next 5Y-39.03%
FCF growth 1Y4.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.05%
OCF growth 3YN/A
OCF growth 5YN/A